Comparison of two different methods for inactivation of viruses in serum

Clinical and Diagnostic Laboratory Immunology

Volumn 4, Issue 5, 1997, Pages 504-508

  Preuss, T ^a,c   Kamstrup, S ^a   Kyvsgaard, N C ^b   Nansen, P ^b   Miller, A ^a   Lei, J C ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AZIRIDINE; BIOMATERIAL;

ARTICLE; DENMARK; ELECTRON BEAM; HUMAN; INFECTION CONTROL; IRRADIATION; NONHUMAN; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS INACTIVATION; VIRUS INFECTION; VIRUS INFECTIVITY;

EID: 0030828879     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.4.5.504-508.1997     Document Type: Article

References (17)

1. Bahnemann, H. G. 1973. The inactivation of foot-and-mouth disease virus by ethylenimine and propylenimine. Zentralbl. Vet. Med. B 20:356-360.
2. Bahnemann, H. G. 1975. Binary ethylenimine as an inactivant for foot-and-mouth disease virus and its application for vaccine production. Arch. Virol. 47:47-56.
3. Bauer, K. 1970. Die Inaktivierung des Maul-und-Klauenseuche (MKS) Virus durch Äthyläthylenimine und die Eignung des inaktivierten Virus zur Impfstoffherstellung. Zentralbl. Bakteriol. Parasitenkd. Infektionskr. Hyg. Abt. 1 Orig. 213:285-297.
4. Blackburn, N. K., and T. G. Besselaar. 1991. A study of the effect of chemical inactivants on the epitopes of Rift Valley fever virus glycoproteins using monoclonal antibodies. J. Virol. Methods 33:367-374.
5. Committee for Proprietary Medicinal Products. 1995. Notes for guidance on virus validation studies: the design, contribution and interpretation of studies validating the inactivation and removal of viruses. CPMP/BWP/268/95. European Agency for Evaluation of Medicinal Products, London, England.
6. Cunliffe, H. R. 1973. Inactivation of foot-and-mouth disease virus with ethylenimine. Appl. Microbiol. 26:747-750.
7. Elliott, L. H., J. B. McCormick, and K. M. Johnson. 1982. Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiation. J. Clin. Microbiol. 16:704-708.
8. Hassanain, M. N. 1992. Preliminary findings for an inactivated African horsesickness vaccine using binary ethylenimine. Rev. Elev. Med. Vet. Pays Trop. 45:221-234.
9. House, C., J. A. House, and R. J. Yedloutsching. 1990. Inactivation of viral agents in bovine serum by gamma irradiation. Can. J. Microbiol. 36:737-740.
10. Huber, W. 1952. Cold sterilization by electron beam as a possible tool for the inactivation of the virus of homologous serum jaundice in plasma. Ann. N. Y. Acad. Sci. 55:536-542.
11. Kyvsgaard, N. C., P. Lind, T. Preuss, S. Kamstrup, J. C. Lei, H. O. Bogh, and P. Nansen. 1996. Activity of antibodies against Salmonella dublin, Toxoplasma gondii, or Actinobacillus pleuropneumoniae in sera after treatment with electron beam irradiation or binary ethylenimine. Clin. Diagn. Lab. Immunol. 3:628-634.
12. Latarjet, R. 1972. Interaction of radiation energy with nucleic acids. Curr. Top. Radiat. Res. Q. 8:1-38.
13. Mahnel, H., H. S. von Brodorott, and K. Ottis. 1980. Empfindlichkeit von Viren gegen Gammastrahlen. Zentralbl. Bakteriol. Parasitenkd. Infektionskr. Hyg. Abt. 1 Orig. Reihe B 170:57-70.
14. May, E. M., D. C. Hunt, and J. Sloggem. 1980. A normal phase high-performance liquid chromatographic assay for aziridine residue in trientine dihydrochloride. J. Pharm. Biomed. Anal. 5:65-70.
15. Mengeling, W. L. 1989. Porcine parvovirus, p. 83-94. In M. B. Pensaert (ed.), Virus infections of porcines. Elsevier Science Publishers B.V., Amsterdam, The Netherlands.
16. 60Co irradiation, and acridine dye in immune assay systems. J. Clin. Microbiol. 8:604-611.
17. Thomas, F. C., A. G. Davies, G. C. Dulac, N. G. Willis, G. Papp-Vid, and A. Girard. 1981. Gamma ray inactivation of some animal viruses. Can. J. Comp. Med. 45:397-399.